David Zaragoza Huesca

Peñas-Martínez J, Luengo-Gil G, Espín S, Bohdan N, Ortega-Sabater C, Ródenas MC, Zaragoza-Huesca D, López-Andreo MJ, Plasencia C, Vicente V, Carmona-Bayonas A, Martínez-Martínez I. Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells. Biomedicines. 2021 May 7;9(5). pii: 523. doi: 10.3390/biomedicines9050523. PubMed PMID: 34067120; PubMed Central PMCID: PMC8151964.

AÑO: 2021; IF: 4.757

34067120

Zaragoza-Huesca D, Garrido-Rodriguez P, Jimenez-Fonseca P, Martinez de Castro E, Sanchez-Canovas M, Visa L, Custodio A, Fernandez-Montes A, Penas-Martinez J, Morales Del Burgo P, Gallego J, Luengo-Gil G, Vicente V, Martinez-Martinez I, Carmona-Bayonas A. Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry. Biomedicines. 2022 Jan 11;10(1):148. doi: 10.3390/biomedicines10010148. PubMed PMID: 35052827; PubMed Central PMCID: PMC8773420.

AÑO: 2022; IF: 4.7

35052827

Zaragoza-Huesca D, Martinez-Cortes C, Banegas-Luna AJ, Perez-Garrido A, Vegara-Meseguer JM, Penas-Martinez J, Rodenas MC, Espin S, Perez-Sanchez H, Martinez-Martinez I. Identification of Kukoamine A, Zeaxanthin, and Clexane as New Furin Inhibitors. Int J Mol Sci. 2022 Mar 3;23(5):2796. doi: 10.3390/ijms23052796. PubMed PMID: 35269938; PubMed Central PMCID: PMC8911046.

AÑO: 2022; IF: 5.6

35269938

Zaragoza-Huesca D, Nieto-Olivares A, Garcia-Molina F, Ricote G, Montenegro S, Sanchez-Canovas M, Garrido-Rodriguez P, Penas-Martinez J, Vicente V, Martinez F, Lozano ML, Carmona-Bayonas A, Martinez-Martinez I. Implication of Hepsin from Primary Tumor in the Prognosis of Colorectal Cancer Patients. Cancers (Basel). 2022 Jun 24;14(13):3106. doi: 10.3390/cancers14133106. PubMed PMID: 35804878; PubMed Central PMCID: PMC9264764.

AÑO: 2022; IF: 6.575

35804878

Rodenas MC, Penas-Martinez J, Pardo-Sanchez I, Zaragoza-Huesca D, Ortega-Sabater C, Pena-Garcia J, Espin S, Ricote G, Montenegro S, Ayala-De La Pena F, Luengo-Gil G, Nieto A, Garcia-Molina F, Vicente V, Bernardi F, Lozano ML, Mulero V, Perez-Sanchez H, Carmona-Bayonas A, Martinez-Martinez I. Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells. Front Mol Biosci. 2023 May 19;10:1182925. doi: 10.3389/fmolb.2023.1182925. eCollection 2023. PubMed PMID: 37275957; PubMed Central PMCID: PMC10235687.

AÑO: 2023; IF: 5.0

37275957